Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Palbociclib plus cetuximab vs placebo plus cetuximab in Japanese patients with cancer
jRCT2080222950Phase 2Completed
- Start
- Aug 2015
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, double-blind trial comparing palbociclib + cetuximab with placebo + cetuximab (2 arms). Primary endpoint: Overall survival. Started Aug 2015; status: completed.
02
Drugs
palbociclib
Beyond the preview
Go deeper on jRCT2080222950.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222950.